Autolus Therapeutics plc (FRA:6A3A)

Autolus Therapeutics Revenue

Autolus Therapeutics had revenue of $45.69M USD in the quarter ending June 30, 2026, with 118.37% growth. This brings the company's total for the last twelve months to $117.39M, up 292.16% year-over-year. In the year 2025, Autolus Therapeutics had annual revenue of $75.39M with 644.94% growth.

• Revenue (ttm): $117.39M
• Revenue Growth: +292.16%
• P/S Ratio: 3.56
• Revenue / Employee: $155.69K
• Employees: 754
• Market Cap: 366.03M EUR

Revenue Chart

Chart

Chart

* This company reports financials in USD.

Revenue by Geography

Chart

• United States of America 75.34M 99.9%
• Europe 50.00K 0.1%

Fiscal year ended Dec 31, 2025 See the full Autolus Therapeutics breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	75.39M	65.27M	644.94%
Dec 31, 2024	10.12M	8.42M	496.00%
Dec 31, 2023	1.70M	-4.68M	-73.38%
Dec 31, 2022	6.38M	4.87M	323.23%
Dec 31, 2021	1.51M	1.27M	522.73%
Dec 31, 2020	242.00K	-	-
Dec 31, 2019	-	-	-
Dec 31, 2018	-	-	-
Sep 30, 2018	-	-	-
Sep 30, 2017	-	-	-
Sep 30, 2016	-	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue geography data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Oct 24, 2026

Data Sources Report a data error